Skip to main content
60°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elicio Therapeutics Inc
(NQ:
ELTX
)
4.340
-0.120 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elicio Therapeutics Inc
< Previous
1
2
3
Next >
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors
January 25, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium
January 17, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference
January 16, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
January 12, 2024
A look at five stocks seeing increased attention from investors.
Via
Benzinga
Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study
January 11, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Unity Layoffs 2024: What to Know About the Latest U Job Cuts
January 09, 2024
Unity layoffs are on the way as the video game software company reveals plans to cut 1,800 jobs to focus on its core business.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today?
January 09, 2024
Cyclacel Pharmaceuticals stock is slipping on Tuesday after shares of CYCC rallied on Monday alongside it regaining Nasdaq compliance.
Via
InvestorPlace
Why Is Grifols (GRFS) Stock Down 38% Today?
January 09, 2024
Grifols stock is falling hard as investors sell GRFS shares after the company was hit with a short report from Gotham City Research.
Via
InvestorPlace
Why Is Elicio Therapeutics (ELTX) Stock Up 11% Today?
January 09, 2024
Elicio Therapeutics stock is up with heavy trading of ELTX shares are posting positive preliminary results from a Phase 1 clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 09, 2024
Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!
Via
InvestorPlace
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
January 09, 2024
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 01, 2024
Via
Benzinga
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 03, 2024
Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.
Via
Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...
Via
Benzinga
Over $2M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
December 27, 2023
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Elicio Therapeutics Announces $7.0 Million Private Placement Financing
December 22, 2023
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
A Look At Elicio Therapeutics’ (NASDAQ: ELTX) Pipeline: What Does This Cancer-Fighting Company Have In Store For The Future?
December 15, 2023
--News Direct--
Via
News Direct
A Look At Elicio Therapeutics' (NASDAQ: ELTX) Pipeline: What Does This Cancer-Fighting Company Have In Store For The Future?
December 14, 2023
Elicio Therapeutics Inc. (NYSE: ELTX) is using precision vaccines, immunomodulators and cell-based therapies to assemble cancer-killing immune responses against both blood and solid tumors.
Via
Benzinga
Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
December 04, 2023
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 09, 2023
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study of ELI-002 and New Preclinical Data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer (SITC 2023) Annual Meeting
November 03, 2023
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Elicio Therapeutics (NASDAQ: ELTX) Reports Promising Progress In Cancer Vaccine Clinical Trials, Placing An Emphasis On The Lymphatic System
November 03, 2023
--News Direct--
Via
News Direct
Elicio Therapeutics (NASDAQ: ELTX) Reports Promising Progress In Cancer Vaccine Clinical Trials, Placing An Emphasis On The Lymphatic System
November 02, 2023
An estimated 609,820 people will die of cancer in the United States this year, according to the National Cancer Institute. Promising results from a 12-year-old clinical-stage biotechnology company have...
Via
Benzinga
How Elicio Therapeutics Is Taking A Different Approach To Treating Cancers Like Colon Cancer, Expected To Be The Leading Killer Cancer By 2030
October 26, 2023
--News Direct--
Via
News Direct
How Elicio Therapeutics Is Taking A Different Approach To Treating Cancers Like Colon Cancer, Expected To Be The Leading Killer Cancer By 2030
October 25, 2023
Founded in 2011, Elicio Therapeutics Inc. (NASDAQ: ELTX) strives to use precision vaccines, immunomodulators and cell-based therapies to assemble cancer-killing immune responses against both blood and...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.